Evidence map›Paper›PMID 17018134›Full record

ArticleRetrovirology2006

Inhibition of PP2A by LIS1 increases HIV-1 gene expression.

Nicolas Epie, Tatyana Ammosova, Willie Turner, Sergei Nekhai

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. SIV-Mediated Synaptic Dysfunction Is Associated with an Increase in Synapsin Site 1 Phosphorylation and Impaired PP2A Activity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  3. Review
  4. Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Curing HIV: Pharmacologic approaches to target HIV-1 latency.Annual review of pharmacology and toxicology · 2011
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicolas EpieCenter for Sickle Cell Disease, Howard University College of Medicine, 520 W Street N.W., Washington, DC 20059, USA. nepie@howard.edu
Tatyana Ammosova
Willie Turner
Sergei Nekhai
Howard University · US

Funding

Labile Iron Pools In Hempglobin S ErythmocytesUH1HL003679 · NHLBI · HOWARD UNIVERSITY · PI GORDEUK, VICTOR R · 1996 to 2004
$3.5M
REGULATION OF HIV-1 TRANSCRIPTION BY CDK2R21AI056973 · NIAID · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2003 to 2004
$494k
NHLBI NIH HHS UH1 HL003679NHLBI NIH HHS UH1 HL03679NIAID NIH HHS AI056973NIAID NIH HHS R21 AI056973
6 · The paper itself

Abstract

backgroundLissencephaly is a severe brain malformation in part caused by mutations in the LIS1 gene. LIS1 interacts with microtubule-associated proteins, and enhances transport of microtubule fragments. Previously we showed that LIS1 interacts with HIV-1 Tat protein and that this interaction was mediated by WD40 domains of LIS1. In the present study, we analyze the effect of LIS1 on Tat-mediated transcription of HIV-1 LTR.

resultsTat-mediated HIV-1 transcription was upregulated in 293 cells transfected with LIS1 expression vector. The WD5 but not the N-terminal domain of LIS1 increases Tat-dependent HIV-1 transcription. The effect of LIS1 was similar to the effect of okadaic acid, an inhibitor of protein phosphatase 2A (PP2A). We then analyzed the effect of LIS1 on the activity of PP2A in vitro. We show that LIS1 and its isolated WD5 domain but not the N-terminal domain of LIS1 blocks PP2A activity.

conclusionOur results show that inhibition of PP2A by LIS1 induces HIV-1 transcription. Our results also point to a possibility that LIS1 might function in the cells as a yet unrecognized regulatory subunit of PP2A.

Indexed as

Up-Regulation1-Alkyl-2-acetylglycerophosphocholine EsteraseCell LineGene Expression Regulation, ViralGene Products, tatHIV-1HIV Long Terminal RepeatHumansMicrotubule-Associated ProteinsPhosphoprotein PhosphatasesProtein Phosphatase 2tat Gene Products, Human Immunodeficiency VirusTranscription, Genetic1-Alkyl-2-acetylglycerophosphocholine EsteraseGene Products, tatMicrotubule-Associated ProteinsPAFAH1B1 protein, humanPhosphoprotein PhosphatasesProtein Phosphatase 2tat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID17018134
PMCPMC1615876
OpenAlexW2172274197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.